Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case report describes an 18-year-old male with kerion celsi from Trichophyton tonsurans infection whose condition improved with terbinafine treatment, and highlights that although IL-17A expression increased in skin lesions, it was associated with disrupted antimicrobial peptide expression and severe inflammation, causing tissue damage.

This case report from Japan detailed a 10-year-old girl with alopecia successfully treated with daily terbinafine, identifying Trichophyton tonsurans as the causative fungus.

This report describes a case of inflammation and infection with specific pathogens in synthetic hair implants done by a non-medical professional, highlighting risks associated with the procedure.

This case report describes a rare instance of tinea capitis caused by Trichophyton tonsurans in a Chinese patient, followed by the development of herpes zoster, suggesting a potential link to immunosuppression.

This case report suggests that regular use of antifungal shampoo might obscure clinical indicators of Trichophyton tonsurans tinea capitis in healthy adults, necessitating detailed diagnostic approaches like histopathology and dermoscopy.

In this case report, a 34-year-old woman with black dot tinea capitis did not respond to oral Itraconazole but was successfully treated with Terbinafine.

This case report describes a 6-month-old girl in China who experienced complete remission of tinea capitis after 8 weeks of treatment with oral fluconazole and ketoconazole cream.

In this study, outbreaks of tinea capitis caused by Trichophyton tonsurans were linked to hairdressing in Sardinian barbershops, with 10 young adult men developing the infection following haircuts; timely treatment is crucial to prevent complications like scarring alopecia.

This case study from Morocco reports the country's first suspected instance of Tinea capitis caused by Trichophyton tonsurans, identified in a 25-year-old member of the national judo team, highlighting the need for screening and improved hygiene in sports environments to prevent potential outbreaks.

This study reported that tinea capitis, though rare in infants under 1 year, should be suspected in those with hair loss or scalp inflammation and can be effectively treated with specific antifungal medications.

This article highlights that a low suspicion for tinea capitis in adults with scaling and hair loss may delay diagnosis and treatment, urging confirmation through KOH, fungal culture, or biopsy.

This article reviews the treatment options for tinea capitis, suggesting that itraconazole, terbinafine, and fluconazole are effective and safe alternatives to griseofulvin but reports no new clinical results.

This case report describes three adults with inflammatory tinea capitis mimicking bacterial infection, emphasizing the need to consider this diagnosis in similar cases; all were successfully treated with oral antifungal agents.

This study found that androgenic steroids, particularly androstenedione and androstanedione, significantly reduced the growth of certain dermatophytes, suggesting hormonal influence on fungal infections in hair follicles.

In this study, Kerion Celsi, a deep fungal scalp infection, is highlighted as being rare in neonates but more common in children over 3 years, requiring medical treatment with antifungals and antibiotics to prevent scarring alopecia and distinguish it from bacterial infections.

In this report, a 51-year-old woman with systemic lupus erythematosus presented with recurrent joint pain and irregular patches of hair loss, raising differential diagnoses of androgenetic alopecia, lupus-related alopecia, or seborrheic dermatitis.

In this study, Trichophyton tonsurans and Microsporum canis were identified as the primary causes of tinea capitis, with terbinafine treatment showing the highest cure rate. Non-commercial kits surpassed real-time PCR commercial kits in specificity and sensitivity for diagnosis.

This review discusses systemic antifungal treatments for tinea capitis in children, noting that newer agents like terbinafine and itraconazole require shorter courses than the traditional griseofulvin, but may be more costly.

This source discusses the diagnosis and treatment of Tinea capitis in children, highlighting that Trichophyton tonsurans is the prevalent cause in the UK and that terbinafine is an effective treatment option.

This article outlines how pediatric hair problems present and how they can be assessed, without reporting new research results.

In this article review, it was reported that systemic oral antifungal treatments are essential for effectively managing tinea capitis, as topical antifungals alone cannot reach the hair follicle roots but may reduce spore transmission when used alongside oral medications.

This case report describes a rare instance of tinea capitis in a 19-year-old male, initially misdiagnosed as dissecting cellulitis, highlighting the need for accurate diagnosis to prevent scarring alopecia.

The boy had a fungal scalp infection called kerion, which was cured with oral antifungal medication.

This study highlights a dissecting cellulitis-like presentation of tinea capitis in children that should be identified to ensure correct diagnosis and treatment to prevent scarring alopecia.

This case report details a 52-year-old man's successful hair regrowth following treatment with griseofulvin for Trichophyton tonsurans-induced scalp ringworm.

This study evaluated a herbal shampoo containing flavonoid glycosides from Dicerocaryum senecioides and found that it successfully treated T. tonsurans infections in children's scalp when used daily, demonstrating significant effectiveness compared to a placebo.

This case study reports that a 9-year-old Nepalese boy with tinea capitis successfully recovered with systemic antifungal therapy, though experienced focal alopecia without recurrence at a two-year follow-up.

This case report describes a high school wrestler whose forearm rash was initially misdiagnosed as eczema, later identified as Majocchi's granuloma, and successfully treated with oral antifungal therapy after a biopsy.

In this in-vitro study, neem leaf extract, combined with oils from Eucalyptus citriodora and Cymbopogon martini, inhibited dermatophyte growth responsible for tinea capitis, showing potential for developing a treatment formulation against the infection.

This case report highlights the importance of maintaining clinical suspicion for tinea incognito in patients with central centrifugal cicatricial alopecia who do not respond to typical corticosteroid treatments, as misdiagnosis can complicate treatment.